Tag: new-multiple
-
Drugged up: GSK, Roche and Sanofi to set out their stalls
By Ben Hirschler LONDON (Reuters) – Three of Europe's top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. GSK's Andrew Witty and Sanofi's new boss Olivier Brandicourt both need to demonstrate recovery potential, after recent disappointments, while Roche's Severin…
-
Factbox: Drugs to watch at Roche, Sanofi and GSK
(Reuters) – GlaxoSmithKline, Roche and Sanofi all hold investor days this week. Below are three new drugs to watch from each company, with consensus annual sales in 2020, according to Thomson Reuters Cortellis. …